AstraZeneca’s diabetes drug Farxiga could face generic competition in the US, after the FDA gave tentative approval to a generic rival from India’s Glenmark, although it is unclear when the ...

Bristol-Myers Squibb and AstraZeneca first joined forces to enable the companies to work together in order to research, develop and commercialise select investigational drugs for type 2 diabetes.

Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for ...

The U.S. government has selected the second batch of drugs up for Medicare price negotiations under the Inflation Reduction ...

Novo Nordisk (NYSE: NVO) and AstraZeneca (NASDAQ: AZN) are among the largest companies in the pharmaceutical industry. Both ...

On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under ...

Drug firm AstraZeneca India on Tuesday said it has received approval from the country's drug regulator to market the anti-diabetes medication Dapagliflozin.The company said it has received ...